Format
Sort by
Items per page

Send to

Choose Destination

Best matches for resistant tuberculosis:

Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis. Dheda K et al. Lancet Respir Med. (2014)

Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis. Seung KJ et al. Cold Spring Harb Perspect Med. (2015)

Evolution and transmission of drug-resistant tuberculosis in a Russian population. Casali N et al. Nat Genet. (2014)

Search results

Items: 1 to 20 of 16389

1.

Incidence and Drug Resistance of Zoonotic Mycobacterium bovis Infection in Peshawar, Pakistan.

Khattak I, Mushtaq MH, Ayaz S, Ali S, Sheed A, Muhammad J, Sohail ML, Amanullah H, Ahmad I, Ur Rahman S.

Adv Exp Med Biol. 2018 Feb 17. doi: 10.1007/5584_2018_170. [Epub ahead of print]

PMID:
29453670
2.

Widespread use of incorrect PCR ramp rate negatively impacts multidrug-resistant tuberculosis diagnosis (MTBDRplus).

Derendinger B, de Vos M, Nathavitharana RR, Dolby T, Simpson JA, van Helden PD, Warren RM, Theron G.

Sci Rep. 2018 Feb 16;8(1):3206. doi: 10.1038/s41598-018-21458-y.

PMID:
29453405
3.

A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK.

Chiarelli LR, Mori G, Orena BS, Esposito M, Lane T, de Jesus Lopes Ribeiro AL, Degiacomi G, Zemanová J, Szádocka S, Huszár S, Palčeková Z, Manfredi M, Gosetti F, Lelièvre J, Ballell L, Kazakova E, Makarov V, Marengo E, Mikusova K, Cole ST, Riccardi G, Ekins S, Pasca MR.

Sci Rep. 2018 Feb 16;8(1):3187. doi: 10.1038/s41598-018-21614-4.

PMID:
29453370
4.

Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study.

Ferlazzo G, Mohr E, Laxmeshwar C, Hewison C, Hughes J, Jonckheere S, Khachatryan N, De Avezedo V, Egazaryan L, Shroufi A, Kalon S, Cox H, Furin J, Isaakidis P.

Lancet Infect Dis. 2018 Feb 13. pii: S1473-3099(18)30100-2. doi: 10.1016/S1473-3099(18)30100-2. [Epub ahead of print]

PMID:
29452942
5.

Combining bedaquiline and delamanid to treat multidrug-resistant tuberculosis.

Tadolini M, Tiberi S, Migliori GB.

Lancet Infect Dis. 2018 Feb 13. pii: S1473-3099(18)30106-3. doi: 10.1016/S1473-3099(18)30106-3. [Epub ahead of print] No abstract available.

PMID:
29452940
6.

Diagnosing isolated hepatosplenic tuberculosis in an immunocompetent patient: a case report.

Dawani O, Khan RS, Syed MJ, Shehzad AM, Alratoot A, Ahmed MF.

Trop Doct. 2018 Jan 1:49475518757625. doi: 10.1177/0049475518757625. [Epub ahead of print]

PMID:
29451432
7.

Molecular epidemiology and drug sensitivity pattern of Mycobacterium tuberculosis strains isolated from pulmonary tuberculosis patients in and around Ambo Town, Central Ethiopia.

Tilahun M, Ameni G, Desta K, Zewude A, Yamuah L, Abebe M, Aseffa A.

PLoS One. 2018 Feb 15;13(2):e0193083. doi: 10.1371/journal.pone.0193083. eCollection 2018.

8.

Adjunctive therapy with V-5 Immunitor (V5) for the treatment of tuberculosis patients: a meta-analysis.

Feng M, Ding Q, Zhong C, Li J, Wang Q, Yuan Z, Dong Y.

Pharmazie. 2016 Sep 1;71(9):499-503. doi: 10.1691/ph.2016.6051.

PMID:
29441844
9.

Drug-Resistant Miliary Tuberculosis in a Child.

Bao Y, Zheng Y.

N Engl J Med. 2018 Feb 15;378(7):e10. doi: 10.1056/NEJMicm1706353. No abstract available.

PMID:
29443677
10.

The ethanolic extract of ashitaba stem (Angelica keskei [Miq.] Koidz) as future antituberculosis.

Kusuma SAF, Iskandar Y, Dewanti MA.

J Adv Pharm Technol Res. 2018 Jan-Mar;9(1):37-41. doi: 10.4103/japtr.JAPTR_283_17.

PMID:
29441323
11.

Harnessing the mTOR Pathway for Tuberculosis Treatment.

Singh P, Subbian S.

Front Microbiol. 2018 Jan 30;9:70. doi: 10.3389/fmicb.2018.00070. eCollection 2018. Review.

12.

Sequelae of multidrug-resistant tuberculosis: protocol for a systematic review and meta-analysis.

Alene KA, Clements ACA, McBryde ES, Jaramillo E, Lonnroth K, Shaweno D, Viney K.

BMJ Open. 2018 Feb 10;8(2):e019593. doi: 10.1136/bmjopen-2017-019593.

13.

Evaluation of Xpert MTB/RIF Assay for Diagnosis of Tuberculosis in Children.

Das A, Anupurba S, Mishra OP, Banerjee T, Tripathi R.

J Trop Pediatr. 2018 Feb 9. doi: 10.1093/tropej/fmy005. [Epub ahead of print]

PMID:
29438536
14.

A comparison of linezolid lung tissue concentrations among patients with drug-resistant tuberculosis.

Kempker RR, Heinrichs MT, Nikolaishvili K, Sabulua I, Bablishvili N, Gogishvili S, Avaliani Z, Little BP, Bernheim A, Derendorf H, Blumberg HM, Vashakidze S, Peloquin CA.

Eur Respir J. 2018 Feb 7;51(2). pii: 1702166. doi: 10.1183/13993003.02166-2017. Print 2018 Feb. No abstract available.

PMID:
29437945
15.

Time to Multidrug-Resistant Tuberculosis Treatment Initiation in Association with Treatment Outcomes in Shanghai, China.

Chen Y, Yuan Z, Shen X, Wu J, Wu Z, Xu B.

Antimicrob Agents Chemother. 2018 Feb 5. pii: AAC.02259-17. doi: 10.1128/AAC.02259-17. [Epub ahead of print]

PMID:
29437632
16.

Drug susceptibility profiling and genetic determinants of drug resistance in Mycobacterium kansasii.

Bakuła Z, Modrzejewska M, Pennings L, Proboszcz M, Safianowska A, Bielecki J, van Ingen J, Jagielski T.

Antimicrob Agents Chemother. 2018 Feb 5. pii: AAC.01788-17. doi: 10.1128/AAC.01788-17. [Epub ahead of print]

PMID:
29437627
17.

Comments on the SEPAR Guidelines for the Diagnosis and Treatment of Drug-Resistant Tuberculosis.

Caminero JA, Caylá JA, García-García JM, García-Pérez FJ, Palacios JJ, Ruiz-Manzano J.

Arch Bronconeumol. 2018 Feb 8. pii: S0300-2896(18)30013-9. doi: 10.1016/j.arbres.2017.12.015. [Epub ahead of print] English, Spanish. No abstract available.

18.

Assessment of GeneXpert GxAlert platform for multi-drug resistant tuberculosis diagnosis and patients' linkage to care in Tanzania.

Mnyambwa NP, Lekule I, Ngadaya ES, Kimaro G, Petrucka P, Kim DJ, Lymo J, Kazwala R, Mosha F, Mfinanga SG.

BMC Res Notes. 2018 Feb 9;11(1):121. doi: 10.1186/s13104-018-3235-7.

19.

Regulatory T Cells Subvert Mycobacterial Containment in Patients Failing Extensively Drug-resistant TB Treatment.

Davids M, Pooran AS, Pietersen E, Wainwright HC, Binder A, Warren R, Dheda K.

Am J Respir Crit Care Med. 2018 Feb 9. doi: 10.1164/rccm.201707-1441OC. [Epub ahead of print]

PMID:
29425052
20.

Prevalence and risk factors of drug-resistant extrapulmonary tuberculosis.

Boonsarngsuk V, Mangkang K, Santinirand P.

Clin Respir J. 2018 Feb 9. doi: 10.1111/crj.12779. [Epub ahead of print]

PMID:
29424965

Supplemental Content

Loading ...
Support Center